Skip to content

Does oral cancer spread to opposite side of neck in advanced stage

Incidence of contralateral neck node metastasis in locally advanced, resectable, lateralized oral squamous cell carcinoma—a prospective interventional study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/075043
Enrollment
104
Registered
2024-10-10
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx

Interventions

Intervention1: Contralateral neck dissection (levels 1b and 2a): In patients undergoing surgery for oral cancers from November 01,2024 till October 31 2026, those who fit the inclusion criteria will b

Sponsors

Dr.Jino JL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Resectable, locally advanced oral SCC (AJCC 8th Edition TNM Stage IVA and IVB), which does not involve or cross the midline—clinical tumor stage T4a or T4b disease in the gingivobuccal complex and T3 tumors of the tongue and floor of the mouth. 2) Ipsilateral nodal involvement with extra-nodal extension (N3b) 3) Biopsy: Poorly differentiated tumor grade 4) No clinical or radiological evidence of contralateral nodal metastasis

Exclusion criteria

Exclusion criteria: 1) Past history of treatment for head and neck cancer 2) Borderline resectable, unresectable, inoperable or metastatic disease at presentation 3) Clinical or radiological evidence of contralateral nodal metastasis 4) Recurrent oral cancer planned for salvage surgery 5) Tumor involving or crossing the midline 6) T1, T2 disease 7) Multiple or synchronous primary tumors in the head and neck 8) Under 18 years of age or over 90 years of age, or who are pregnant or otherwise vulnerable

Design outcomes

Primary

MeasureTime frame
Incidence of contralateral nodal metastasis in histopathological specimenTimepoint: Post surgery, second week - when the histopathological report comes, Post surgery follow-up at 3months, 6months. 9 months and one year

Secondary

MeasureTime frame
1)To correlate the incidence of contralateral nodal metastasis with other clinicopathological adverse prognostic factors in oral squamous cell carcinoma. 2)To develop a statistical model incorporating predictive factors for contralateral nodal metastasis to guide the need for contralateral neck dissection for oral squamous cell carcinoma. Timepoint: Post operative period;Contralateral nodal recurrence rateTimepoint: one year

Countries

India

Contacts

Public ContactJino JL

Christian medical college and hospital

vidya5feb@gmail.com9585222696

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026